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disease, the JJIS stent is indicated in only bifurcational nd 
internal carotid lesions. The 294 stent was unreasonably 
long in this segment of the carotid artery, which is directly 
exposed to external compression. If for some reason, and I 
cannot imagine why, the JJIS stent was the only option, 
then that stent should have been the much shorter JJIS 
154. After all, the illustrated angiogram demonstrates a 
quite focal lesion, and the short stent would have been 
quite adequate. 
The deformation of the stent that did occur as found 
on the follow-up study appears to be less than 40%. The 
intimal hyperplasia, however, and the restenosis at the 
target site were quite significant and approached at least 
80%. The preliminary data from seven U.S. centers that are 
involved in the carotid stent registry have described stent 
deformation occurring in fewer than 2% of cases and a 
restenosis rate at 6 months of less than 5%. 
The authors' initial decision to use a self-expanding 
flexible Wallstent (Schneider, Minneapolis, Minn.) was 
quite appropriate, realizing that the Wallstent has a flexibil- 
ity feature and is "noncrushable" and would have been 
quite satisfactory for this segment of the carotid artery. 
Discovering, however, that they did not have the ade- 
quate-length stent after they had initiated the procedure 
and were ready for deployment was difficult to explain. The 
procedure should have been terminated at this point. Fur- 
thermore, the authors chose a polyethylene t rephthalate 
balloon for stent deployment with a 0.035 inch wire passed 
across the target lesion and left within the internal carotid 
artery during the deployment process. 
Although the authors discuss the widespread use of 
"off-label applications of endovascular stents," the ques- 
tion occurs whether this particular procedure was per- 
formed under an approved Investigational Device Exemp- 
tion protocol? 
Endovascular stenting for carotid occlusive disease is 
evolving as an alternative to the "gold-standard" ofcarotid 
endarterectomy, but until significant registry data or ran- 
domized controls establish its efficacy and safety, this pro- 
cedure should be confined to experienced centers. 
Mark H. Wholey, MD 
Chairman 
Pittsburgh Vascular Institute 
5230 Centre Ave. 
Pittsburgh, PA 15232 
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Reply 
To the Editors: 
The authors appreciate Dr. Wholey's comments on our 
article and would like to respond. While we recognize that 
stent technology and deployment techniques are continu- 
ally evolving, it should be noted that this case was per- 
formed in 1994, using techniques considered optimal at 
that time. In addition, we would like to point out that the 
placement of the stent occurred without complication. As 
Roubin et al. stated in their symposium on carotid stenting 
at the Society for Cardiovascular nd Interventional Radi- 
ology's (SCVIR) 22nd Meeting, "the optimal technique 
for carotid stent placement has not been determined," and 
"optimal wire guides, delivery sheaths, balloons, and stents 
have not yet been determined. "1
Dr. Wholey states that he "cannot imagine why a 
Palmaz stent" was the only option. We would like to clarify 
that the reason the Wallstent was not placed was because 
the deployment delivery device was not long enough, not 
because we did not have an adequate-length stent. At the 
time of this procedure, the Wallstent was only available in a 
usable delivery length of 75 cm, which was not long 
enough for adequate deployment from a femoral approach. 
It currently is available in several deployment lengths, in- 
cluding a 135 cm usable delivery system that easily allows 
placement from a femoral approach. Therefore, with the 
possible exception of using a 7F brachial approach, the 
Palmaz stent was the only choice in this patient. The flap 
and intimal irregularity extended over a 1 cm area, and this 
is the reason for the choice of stent length. Furthermore, 
both the 154 and 294 stents are equally prone to deforma- 
tion because they have the same radial hoop strength. 
The point of this case was to illustrate the theoretical 
but previously unpublished concern of placing a deform- 
able stent in the cervical carotid system. Except in the 
situation of a high bifurcation of the carotid artery, the 
distal common carotid artery, bifurcation, and proximal 
internal carotid artery are all located in exposed, potentially 
compressible locations. It should be noted that in Dr. 
Wholey's abstract from this year's SCVIR meeting entitled 
"Endovascular stents for carotid occlusive disease," seven 
of the 58 patients in his subject group who underwent 
carotid stenting had a Palmaz stent placed in the common 
carotid artery. 2
Dr. Wholey cites data on 58 patients from seven cen- 
ters in the carotid stent registry, noting only a 2% deforma- 
tion rate. Other investigators have noted a significantly 
higher rate of Palmaz stent deformation in the carotid 
artery. Vitek et al.,3 who probably have the largest experi- 
ence in the United States, noted a 13% rate ofstent defor- 
mation at 6-month follow-up in the 203 patients they 
treated with balloon-expandable st nts. They concluded 
"because of the risk of stent deformation of balloon-ex- 
pandable stents, it is more appropriate to use the self- 
expandable stents'. 3 
In 1994, this procedure was performed as an off-label 
use of a FDA-approved evice for compassionate reasons. 
The FDA has since clarified clinical research of carotid 
stenting, and we agree with Dr. Wholey that any current 
placements in the United States should be done under 
IRB- and IDE-approved protocols. We are not currently 
performing carotid procedures because we are not satisfied 
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with the current stents on the market for carotid stenting. 
We agree that this procedure should be confined to expe- 
rienced centers. Our institution, Wilford Hall Medical 
Center, clearly meets these criteria, as it has four full-time 
interventional radiologists and was one of the first 25 
centers in the country to receive fellowship accreditation. 
Because of our affiliation with the University of Texas, San 
Antonio, we were one of the first institutions in the United 
States to begin placing the Palmaz stent. 
Stephen P.Johnson, MD 
Department ofRadiology/PSRD 
Wilford Hall Medical Center 
2200 Bergquist Dr. 
Lackland AFB, TX 78236-5300 
REFERENCES 
1. Roubin GS, Vitek JJ, Sriram I, Yadav SS, Gomez C. Sympo- 
sium on carotid stenting. J Vasc Interv Radiol 1997;8(suppl 
2):25-8. 
2. Wholey MH, Wholey MH, Eles G. Endovascular stents for 
carotid occlusive disease. J Vasc Interv Radiol 1997;8(suppl 
2);210-1. 
3. Vitek JJ, Yadav SS, Iyer SS, Roubin SS. Update on carotid 
angioplasty with stenting in atherosclerotic disease: compari- 
son in between balloon expandable and self-expanding stents. 
Proceedings of the 35th Annual Meeting American Society of 
Neuroradiology, p. 99-100. 
24/41/84940 
